Edit |   |
---|---|
Antigenic Specificity | Neuropilin-1/NRP1/VEGF165R extracellular domain (Vesencumab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Vesencumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Neuropilin-1/NRP1/VEGF165R extracellular domain, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Vesencumab is under investigation in clinical trial NCT00747734 (A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors). |
Immunogen | n/a |
Other Names | Vesencumab, Neuropilin-1/NRP1/VEGF165R extracellular domain, 1205533-60-3 |
Gene, Accession # | CAS: 1205533-60-3 |
Catalog # | abx831221 |
Price | please inquire |
Order / More Info | Neuropilin-1/NRP1/VEGF165R extracellular domain (Vesencumab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950